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Edited by Gianni CesareniAbstract We describe the behavior of a polypeptide consisting
of the genetic fusion of a structurally stable single-domain pro-
tein, EGFP (an analog of the green ﬂuorescent protein) with
an amyloidogenic sequence, retroCspA (known to readily form
amyloid ﬁbrils). Refolding of the fusion protein through single-
step removal of denaturant and salt results in precipitation into
amyloid aggregates displaying ﬁbrillar morphology, thioﬂavin
T binding as well as green ﬂuorescence. Refolding through
step-wise reduction of denaturant concentration in the presence
of salt yields a soluble aggregate containing a folded,
thermally-stable, non-ﬂuorescent EGFP domain. Together, these
results indicate that retroCspA forces the fusion protein to
aggregate; however, the EGFP domain remains folded in a
native-like structural format in both soluble aggregates and pre-
cipitates.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: Beta sheet propagation; Amyloid formation; Stable
protein domains; Fusion proteins; Conformational change1. Introduction
Polypeptide chains within amyloid ﬁbrils tend to be orga-
nized into cross-beta structures that have b-strands running
perpendicular to the long axis of the ﬁbril [1]. Many diﬀerent
proteins with diﬀerent secondary structural compositions are
reported to form amyloid ﬁbrils, following prolonged incuba-
tion in structurally-destabilizing (e.g., acidic) environments
[2–4]. Formation of amyloids can thus involve profound
changes in protein conformation, suggesting that the ease with
which a given protein transforms into amyloid ﬁbrils may be
correlated with the extent to which its native structure is ame-
nable to structural reorganization, i.e., with the degree to
which its structure is thermodynamically and kinetically stable.
Support for this view comes from reports indicating that, for
naturally-occurring proteins, the presence of disordered poly-*Corresponding author. Address: Protein Science and Engineering
Division, Institute of Microbial Technology (IMTECH), Chandigarh
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doi:10.1016/j.febslet.2008.05.008peptide chain segments and/or conditions favorable to unfold-
ing could be required for deposition into amyloid forms [5]. A
detailed comparison of the kinetics, and quantum, of amyloid
formation shown by diﬀerent proteins of diﬀerent (known)
structural contents, and stabilities, could be expected to pro-
vide critical insights in this regard. However, in this paper,
we have taken a diﬀerent approach to explore how protein
structural stability relates to amyloid-forming potential.
We genetically fused a known amyloid-forming polypeptide
sequence to the C-terminus of a single-domain protein of high
structural stability, to examine whether the amyloidogenic se-
quence pulls the stable domain down with it into a precipi-
tated, amyloid-like state and, if so, whether the stable
domain is deposited in a native-like, or reorganized, structure.
Since a short amyloidogenic sequence fused to a large stable
protein domain could fail to engage in intermolecular interac-
tions for purely steric reasons, we decided arbitrarily that the
length of the amyloidogenic sequence would need to be about
one-half or at least one-third the length of the stable domain,
to keep the latter from sterically occluding the former.
We chose the 238 amino acids-long enhanced analog
(EGFP) of the well-known green ﬂuorescent protein (GFP)
of Aquorea Victoria [6], as the stable protein domain. The
EGFP domain is an ideal choice as a stable domain for three
reasons: (1) it refolds quantitatively within minutes of removal
of denaturant without any attendant aggregation [7]; (2) it
requires either an extreme of pH (pH < 4.0 or >12.0), or a
combination of high denaturant concentration (6 M guanidi-
nium hydrochloride) and high temperature (90 C), to undergo
any detectable unfolding [8]; and (3) it shows the characteristic
GFP ﬂuorescence that serves as a spectroscopic signature of
native conformational status, since GFP ﬂuorescence is
known to be critically dependent on the maintenance of the
correct three-dimensional structure, with dramatic quenching
accompanying even the slightest structural deformation [9].
To the C-terminus of the EGFP domain, we fused an amyloi-
dogenic polypeptide encoding a backbone-reversed form of the
cold shock protein A of Escherichia coli (retroCspA). This 82
residues-long polypeptide is an ideal choice as an amyloidogen
because it is known to readily and quantitatively form amyloid
ﬁbrils in aqueous solution over a timescale of hours at room
temperature, following puriﬁcation and refolding, without
requiring any speciﬁc conditions for amyloid formation [10].
Below, we describe our ﬁndings which suggest that the
EGFP-retroCspA fusion protein forms soluble or insoluble
(amyloid) aggregates, depending on the manner of refolding,blished by Elsevier B.V. All rights reserved.
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also show that retroCspA pulls the EGFP domain down into
insoluble aggregates within which the EGFP domain remains
quantitatively folded, displaying green ﬂuorescence.2. Materials and methods
2.1. Creation of the EGFP-T-retroCspA fusion construct
The DNA construct (see supplementary Fig. S1) encoding the
EGFP-T-retroCspA fusion protein encodes the EGFP sequence at its
5 0 end and the retroCspA sequence at its 3 0 end, separated by a throm-
bin cleavage sequence (also functioning as a ﬂexible linker), with a
total length of 335 amino acids and a calculated molecular weight of
37.4 kDa. The thrombin cleavage site was introduced to separate the
fusion partners if necessary, at any stage of the studies, and also to pro-
vide the two proteins with the ﬂexibility to be somewhat independent
of each other and thus display their own characteristic behavioral fea-
tures. Several PCR reactions were performed to create the construct, as
described below. The ﬁrst PCR reaction was carried out with primers
that ampliﬁed the EGFP sequence from the pEGFP vector (Clontech)
to incorporate a 5xHis sequence for aﬃnity puriﬁcation at the 5 0 end of
the EGFP domain, along with a thrombin cleavage sequence at the 3 0
end of the EGFP domain. The forward and reverse primers speciﬁed
below were used for this reaction. Forward Primer 1: 5 0 TAT ACT
CCA AGC TTG CAT CAT CAT CAC CAC ATG GTG AGC
AAG GGC GAG 3 0. Reverse Primer 1: 5 0 GTG ATG CGG GGA
TCC ACG TGG AAC CAG CTT GTA CAG CTC GTC CAT
GCC 3 0. For the second PCR reaction (preparing retroCspA for genet-
ic fusion), it may be noted that a gene encoding retroCspA was already
available in the lab, cloned into the Qiagen pQE-30 vector [10]. We
ampliﬁed the retroCspA sequence from the pQE-30vector using the
following primers, which modiﬁed the sequence at its 5 0 end to incor-
porate the necessary overlapping sequences for splicing by overlap-
extension (SOE) PCR with the 3 0 end of the EGFP-encoding construct:
Forward Primer 2: 5 0 CCA CGT GGA TCC CCG CAT CAC CAT
CAC CAT CAC CTG AGC ACC 3 0. Reverse Primer 2: 5 0 ACT
GTC GCG GCC GCT TTA CAT GGA ACC TTT CAT AGT
ACC 3 0. The forward primer 2 also incorporates a 6xHis encoding se-
quence that become located at the 5 0 end of the retroCspA gene, and
the reverse primer 2 incorporates a NotI restriction site at the 3 0 end
of the retroCspA gene, for cloning into the pEGFP vector. In a third
PCR reaction, the products of the ﬁrst and the second reactions were
cleaned up and joined through SOE PCR using the forward primer 1
and reverse primer 2 speciﬁed above, to create a full-length gene encod-Fig. 1. Panel A: Insolubility of the fusion protein and lack of its presence in ly
of lysed cells expressing EGFP-T-retroCspA; lane 2: supernatant of lysed c
through (lane 4); lane 5: Ni-NTA column wash. Panel B: MALDI-TOF ma
heat, salt and denaturant, puriﬁcation by Ni-NTA chromatography, and pring the fusion, EGFP-T-retroCspA, with T denoting a thrombin
cleavage site. The ﬁnal PCR product and the pEGFP vector were dou-
ble digested with HindIII and NotI enzymes, ligated, and transformed
into BL21(DE3)pLysS E. coli. Protein was produced through overex-
pression induced by IPTG.
2.2. Expression of recombinant proteins
Overnight grown cultures of bacteria containing pEGFP clones
encoding EGFP-T-retroCspA were inoculated at a ﬁnal concentration
of 1% of total volume into LB medium containing appropriate antibi-
otics and grown to an OD600 of 0.6 at 37 C with shaking at 220 rpm.
Cells were induced with 0.5 mM IPTG and grown for a further period
of 5 h at 30 C after induction. Appropriate amounts of control (unin-
duced) and induced cultures (after 2 h and 4 h of induction) were each
loaded on SDS–PAGE after harvesting and boiling of cells in SDS–
PAGE sample buﬀer, to check for expression of the recombinant pro-
tein EGFP-T-retroCspA protein.
2.3. Denaturing puriﬁcation of EGFP-T-retroCspA
The EGFP-T-retroCspA fusion polypeptide deposited within inclu-
sion bodies upon production (see Fig. 1A) and could not be recovered
in soluble form after bacterial cell lysis by either of the two standard
procedures for aﬃnity puriﬁcation suggested by the Ni-NTA resin
manufacturer (Qiagen), i.e., using either denaturing (8 M urea- or
6 M GdmCl-containing) buﬀers, or non-denaturing buﬀers. Therefore,
we tested combinations of diﬀerent denaturing inﬂuences to solubilize
the fusion from the cell lysis pellet, and ﬁnally managed to solubilize it
by using a combination of heat, salt and 6 M GdmCl, as described be-
low. First we suspended the cell pellet in extraction buﬀer containing
6 M GdmCl, 1 M NaCl, 0.1 M NaH2PO4, 0.01 M Tris, pH8.0 at
5 ml per gram wet weight, with shaking at 37 C for 30 min. This
was followed by heating of the suspension at 70 C for 30 min, after
which the suspension was sonicated for 10–15 min. The lysate was then
spun at 15000 · g for 1 h and the supernatant loaded onto a Ni-NTA
column pre-equilibrated with the same buﬀer. After collecting the col-
umns ﬂow-through, the column was re-equilibrated with a urea-con-
taining buﬀer (8 M urea, 10 mM Tris, pH 8.0, 1 M NaCl, 0.1 M
NaH2PO4) that eﬀectively replaced the GdmCl-containing buﬀer used
at earlier stages. Hereafter, we proceeded with the standard protocol
for Ni-NTA puriﬁcation under denaturing conditions suggested by
the resin manufacturer (Qiagen). It may be noted that we also
attempted to extract the fusion protein by individually using heat,
salt and denaturant, and combinations of two of these factors, to try
and dissect out which of the three factor(s) were predominantly
responsible for the extraction. We discovered that extraction occurred
only by using a combination of all three factors, i.e., denaturant (6 Msed cell supernatants, as evidenced by SDS–PAGE data. Lane 1: Pellets
ells; lane 3: molecular weight markers; lane 4: Ni-NTA column ﬂow
ss spectrum of the EGFP-T-retroCspA fusion, following extraction by
ecipitation through refolding.
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combination of two factors, achieved solubilization of the fusion (data
not shown).
2.4. Refolding of EGFP-T-retroCspA through step-wise removal of
denaturant while retaining salt
The urea in the puriﬁed protein fractions eluted from the Ni-NTA
column was removed through step-wise dialysis against a 100-fold
higher volume of 50 mM Tris pH 8.5 buﬀer containing 1 M NaCl
and progressively lower concentrations of urea (diﬀering by 1 M urea),
down from 8 M urea, with the ﬁnal dialysis performed to remove 1 M
urea against a buﬀer containing no urea, and employing multiple buﬀer
changes. Under these conditions, very little visible aggregation was
seen. The solution was centrifuged at 12000·g for 30 min and the
supernatant was subjected to further studies.
2.5. Refolding of EGFP-T-retroCspA through single-step removal of
denaturant and salt
A second method was used to remove the urea from puriﬁed pro-
tein fractions eluted from the Ni-NTA column, as follows. The 8 M
urea-containing solution was directly dialyzed against 20 mM Tris
pH 8.0 buﬀer containing no NaCl. This direct dialysis against a solu-
tion lacking salt led to very heavy aggregation and precipitation of the
fusion protein, unlike what was seen during step-wise dialysis done
with 1 M NaCl retained on both sides of the dialysis membrane (see
Section 2.4). The obtained precipitate was repeatedly washed with
the same buﬀer to remove any soluble protein, and subjected to fur-
ther studies.
2.6. Protein concentration estimation and UV/visible absorption
spectroscopy
Concentration of puriﬁed EGFP-T-retroCspA protein was esti-
mated through measurement of absorbance at 280 nm (A280nm). The
value obtained was compared to the theoretically predicted value
based on amino acid composition, determined using Vector NTI soft-
ware. An absorbance of 1.0 at 280 nm was taken to correspond to a
protein concentration of 1.39 mg/ml. UV/visible absorption studies
were performed on a Cary 50-Bio spectrophotometer.
2.7. Gel ﬁltration chromatography
The gel ﬁltration elution proﬁle of EGFP-T-retroCspA was acquired
on a Pharmacia SMART system ﬁtted with Superdex-75 or Superdex-
200 micro-columns, each of 2.4 ml bed volume. Samples of 50 ll vol-
ume were loaded for micro-puriﬁcation or analysis of changes in
hydrodynamic volumes. Elution volumes were compared with a cali-
bration proﬁle collected using protein standards. Fusion protein elu-
tions were simultaneously monitored using light of 220 (peptide
absorption), 280 (protein aromatic absorption), and 488 nm (EGFP
chromophore absorption), as appropriate.
2.8. Fluorescence spectroscopy
Fluorescence spectra were acquired on a Perkin–Elmer LS-50B
spectroﬂuorimeter, or a Jasco J-810 spectropolarimeter ﬁtted with
a ﬂuorimetric (FMO-427) monochromator attachment. For GFP
emission, 478 nm excitation was used, with emission being recorded
between 497 and 550 nm. Excitation and emission bandpasses were
set at 5 and 10 nm, respectively, with scanning done at 60 nm/min,
and with all spectra averaged over 10 scans. For emission studies of
thioﬂavin T (ThT, which is known to become strongly ﬂuorescent
upon binding to amyloid ﬁbrils), protein samples were incubated
for 1 h with ThT (using a ﬁnal ThT concentration of 6 lM with
protein suspended in 10 mM Tris, pH 8.0) and emission was mon-
itored between 455 and 550 nm, using 444 nm excitation, excitation
and emission bandpasses of 7 nm each, and scanning at 100 nm per
minute.
2.9. Circular dichroism (CD) spectroscopy
Far-UV CD spectra were collected on a Jasco J810 CD spectrometer
in cuvettes of appropriate path lengths (1 cm/0.5 cm/0.2 cm) with ﬂush-
ing of Iolar grade I nitrogen gas at 6–12 l/min. Ellipticity data was col-
lected in the range of 250–190 or 250–200 nm. Raw ellipticity was
converted to mean residue ellipticity [h] using the formula shown be-
low, in which MRW stand for mean residue weight (total molecularweight of the protein/ total number of amino acids), [h] stands for
mean residue ellipticity, expressed in degrees cm2 dmol1. hobs stands
for observed (raw) ellipticity in millidegrees:
½h ¼ fhobs  100MRWg=f1000 concentration ðmg=mlÞ
 path length ðcmÞg2.10. MALDI-TOF mass spectrometry
MALDI-TOF mass spectral measurements were performed on an
ABI Voyager DE-STR spectrometer (Applied Biosystems). Protein
samples were prepared for analysis by mixing with an equal volume
of solution containing the matrix (Sinapinic acid), and loading a total
volume of 2 ll per well of the sample plate. Samples were setup in
duplicates, or triplicates. Matrix solution stocks (10 mg/ml) were pre-
pared in 0.3% TFA (triﬂuoroacetic acid), 50% acetonitrile.
2.11. Detection of ﬂuorescence and imaging of insoluble EGFP-T-retroCspA
aggregates
Precipitated aggregates were visualized through excitation by the
488nm laser on a Zeiss Confocal LSM 510 Meta microscope. Fluores-
cence spectra were recorded on the Jasco J-810 spectropolarimeter, fol-
lowing suspension of aggregates. For the EGFP emission spectrum, a
suspension of aggregated fusion protein was excited by 478 nm wave-
length, with excitation and emission bandpasses set at 7 nm each.
2.12. Electron microscopy
Transmission electron microscopy (TEM) of the protein aggregates
was done in a JEOL 1200 EX2 microscope using negative staining with
phosphotungstic acid (PTA) and uranyl acetate, using standard proto-
cols.3. Results and discussion
3.1. Fusion protein behavior during expression
Within the E. coli BL21(DE3)pLysS cells used as expression
host, EGFP-T-retroCspA was found to have been expressed to
high levels. The cells were brightly ﬂuorescent, showing the
characteristic green ﬂuorescence of GFP or EGFP, upon exci-
tation with ultraviolet light from a standard laboratory UV
torch. However, all of the expressed protein was in insoluble
aggregates, with no soluble protein detectable in the superna-
tant upon centrifugation of bacterial cell lysates (Fig. 1A).
No solubilization/extraction of the insoluble fusion protein
could be achieved even through use of 8 M urea, or 6 M
GdmCl. Only by using a combination of heat (70 C), salt
(1 M NaCl) and denaturant (6 M GdnCl) could EGFP-T-ret-
roCspA be extracted from the deposits and solubilized. GFP,
or EGFP, domains are themselves highly soluble, and also
amongst the most fusion-friendly proteins known to man; fu-
sions of these domains with various other proteins are com-
monly used as cytoplamically-soluble ﬂuorescent reporters of
protein cellular localization. Prima facie, therefore, it would
seem that it is the presence of the retroCspA chain in fusion
with EGFP which causes EGFP-T-retroCspA to precipitate
into urea- and GdnCl-insoluble aggregates during biosynthe-
sis.
We proceeded to try and obtain the fusion protein in a sol-
uble and unfolded form, as described above, by using a combi-
nation of salt, heat and denaturant (see also Section 2.3), to
examine its ability to refold to soluble folded form and/or
aggregate and precipitate. We solubilized EGFP-T-retroCspA
from pellets of lysed bacterial cells, cooled the extracts, con-
ﬁrmed by SDS-PAGE whether the protein had been solubi-
lized and extracted, performed IMAC puriﬁcation of the
2206 S. Sharma, P. Guptasarma / FEBS Letters 582 (2008) 2203–2211fusion protein in the presence of denaturant and salt on a Ni-
NTA column (see supplementary Fig. S2). We then dialyzed
samples to remove the denaturant and salt used for solubiliza-
tion/extraction through a single-step dialysis procedure (see
Section 2.5), and found that the fusion protein precipitates into
solid aggregates. The characteristics of these aggregates are de-
scribed in the following sections.
3.2. EGFP-T-retroCspA precipitates contain full-length fusion
protein
Insoluble aggregates of the EGFP-T-retroCspA were ob-
tained through single-step dialysis of the puriﬁed denatured pro-
tein into 20 mM Tris, pH 8.0 buﬀer lacking NaCl. These were
repeatedly washed through cycles of resuspension in buﬀer,
and centrifugation, to ensure the absence of trace amount of
any soluble protein. The washed aggregate was then solubilized
in acetonitrile containing 0.1% triﬂuoroacetic acid and sinapinic
acid and subjected to MALDI-TOF mass spectrometry, to
examine whether the aggregates contain only the fusion poly-
peptide construct, or also some naturally proteolysis-derived
populations of free EGFP domain, or retroCspA. Fig. 1B estab-
lishes that the aggregated sample consists entirely of the full-
length fusion protein, characterized by a single sharp peak of
the correct expected mass.
3.3. EGFP-T-retroCspA precipitates show EGFP ﬂuorescence
Washed EGFP-T-retroCspA aggregates showed a visible
green color under ordinary conditions of room lighting, akin
to the color associated with a solution of puriﬁed concentratedFig. 2. Green ﬂuorescence in EGFP-T-retroCspA precipitates. Panel A: F
retroCspA precipitates excited by 478 nm light. Panel B: Confocal microscop
material, acquired through excitation of solid aggregates by 488 nm laser ligGFP, owing presumably to the capability of natural lighting to
excite the green ﬂuorescence. The aggregates were suspended
in buﬀer, and examined for GFP ﬂuorescence on a spectroﬂu-
orimeter, with light of 478 nm used for excitation instead of
light of 488 nm, in order to reduce the Rayleigh scatter compo-
nent from the short-wavelength end of the EGFP emission
spectrum (this being necessitated by the closeness of the excita-
tion and emission maximal wavelengths of EGFP, and the
heightened Rayleigh scattering expected from suspended
aggregates). As Fig. 2A shows, a very clear emission from
the EGFP green ﬂuorophore is seen in the suspended aggre-
gate with a peak at 508 nm, indicating the presence of folded
EGFP protein chains in native conformation in the population
of resuspended insoluble aggregates. Further, we also exam-
ined the aggregates on a confocal microscope through excita-
tion by 488 nm light from an Argon laser. Fig. 2A–C, which
represent diﬀerent clumps of aggregates within the ﬁeld of
the confocal microscope, show that the aggregates display a
uniform green EGFP ﬂuorescence. This conﬁrms that folded,
and ﬂuorescent, EGFP is indeed incorporated into the solid
precipitates, because the EGFP ﬂuorophore is well known to
be protected and stabilized by the tertiary structure of the
green ﬂuorescent protein, with the slightest perturbations of
tertiary structure severely quenching ﬂuorescence.
3.4. EGFP-T-retroCspA precipitates contain amyloid-like nanoﬁbril
structures
Fig. 3A and B show representative TEM photomicrographs
of two ﬁelds of fusion protein aggregates containing isolatedluorescence emission spectrum of washed and resuspended EGFP-T-
ic ﬂuorescence images of EGFP ﬂuorescence from within precipitated
ht.
Fig. 3. Amyloid formation by EGFP-T-retroCspA. Panels A and B: Transmission electron micrographs of EGFP-T-retroCspA precipitates at two
diﬀerent magniﬁcations, showing a ﬁlamentous-beaded morphology, with interspersing of electron-dense and non-dense regions. Panel C:
Fluorescence emission from thioﬂavin T (ThT) bound to resuspended EGFP-T-retroCspA precipitated; the dotted line represents the emission from
the control ThT solution (6 lM) in 10 mM Tris, pH 8.0 buﬀer, and the solid line represents the emission from the same concentration of ThT in the
presence of resuspended EGFP-T-retroCspA precipitates.
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arise, in all likelihood, from the amyloid-forming propensity
of the retroCspA component known to readily form amyloid
ﬁbers [10]. However, the ﬁbers seen in the micrograph diﬀer
signiﬁcantly in morphology from the ﬁbrils made by retroC-
spA on its own; also, an interspersing of electron-dense and
non-dense structures, as well as branching, can be seen all
along the ﬁbers in the magniﬁed photomicrograph in Fig. 3B.
3.5. Thioﬂavin T binds to EGFP-T-retroCspA precipitates
To examine whether the ﬁber-like fusion protein precipitates
also contain amyloid-like microstructure, we carried out the
well-known ThT binding assay. This assay is commonly used
to detect cross-beta structures, because ThT intercalates into
cross-beta structures formed by beta strands in amyloid ﬁbrils
and displays ﬂuorescence upon excitation with 444 nm light,
with peak emission at 482 nm. Fig. 3C shows the emission
of ThT bound to suspended precipitates of EGFP-T-retroC-
spA, displaying the characteristic 482 nm emission peak,
conﬁrming the presence of amyloid microstructures.3.6. High molecular weight soluble aggregates of EGFP-T-
retroCspA
To examine whether EGFP-T-retroCspA can be kept from
precipitating during removal of denaturant, we attempted var-
ious combinations of procedures. We found that use of a step-
wise dialysis procedure eﬀecting gradual removal of the urea in
steps of 1 M, combined with retention of 1 M NaCl on both
sides of the dialysis membrane (see Section 2.4) caused
EGFP-T-retroCspA to remain soluble, showing no precipita-
tion even upon complete removal of urea through extensive
dialysis of the ﬁnal 1 M urea-containing solutions in the last
step of this step-wise dialysis. The secondary, tertiary and qua-
ternary structural features of this soluble EGFP-T-retroCspA
fusion, as well as its thermal stability characteristics, were stud-
ied. Puriﬁed, soluble EGFP-T-retroCspA was chromato-
graphed on a superdex-200 gel ﬁltration column in 20 mM
Tris, pH 8.0 buﬀer (SMART system, Pharmacia) to examine
its hydrodynamic volume and quaternary structural state.
Fig. 4A and B shows the elution proﬁles of the puriﬁed
EGFP-T-retroCspA and wild-type EGFP. Both panels show
Fig. 4. Panel A: Gel ﬁltration elution proﬁles of puriﬁed soluble EGFP-T-retroCspA on a Superdex 200 SMART column, showing 280 nm (dark
line) and 488 nm absorbance (light line). Panel B: Gel ﬁltration elution proﬁles of control green ﬂuorescent protein on the same column, showing
280 nm (dark line) and 488 nm absorbance (light line). Panel C: Far-UV CD spectra of soluble EGFP-T-retroCspA aggregates (red) and green
ﬂuorescent protein (green) at 25 C. Panel D: Change in the 218 nm MRE signal of soluble EGFP-T-retroCspA as a function of increasing (black)
and decreasing (red) temperature.
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in terms of 280 nm absorbance owing to aromatic residues (left
Y-axis) as well as 488 nm absorbance owing to the EGFP
chromophore (right Y-axis). Monitoring of both absorptions
allows speciﬁc assessment of which eluting components con-
tain the EGFP chromophore. As Fig. 4A shows, the form of
the protein displaying absorption at both 280 and 488 nm
elutes at 0.9 ml, close to the void volume of the column
(the columns bed volume is 2.4 ml). Elution at the columns
void volume indicates that the protein exists entirely as soluble
aggregates, larger in size than 600000 Da, since the Superdex-
200 column optimally fractionates proteins between 10000 and
600000 Da, and has an exclusion limit of 1.3 · 106 Da. In con-
trast, Fig. 4B shows that the puriﬁed wild-type EGFP control
lacking the C-terminal retroCspA extension elutes at 1.68 ml,
corresponding to the expected elution volume of a monomeric
protein of 26.8 kDa (the size of the EGFP domain). From this
data, it may be inferred that if the EGFP domain in the fusion
protein remains folded into a native-like structural format, the
multimeric soluble aggregates must form because of intermo-
lecular associations of the aggregation-prone retroCspA se-
quences in the fusion construct. In the following sections, we
establish that the EGFP domains in these soluble HMW sam-ples are indeed fully folded and native-like, although with
some diﬀerences in stability.
3.7. Soluble EGFP-T-retroCspA secondary structure: Folded
EGFP and retroCspA
Fig. 4C shows the far-UV CD spectrum of the puriﬁed sol-
uble high molecular weight fusion protein aggregates at 25 C,
together with the spectrum of the control EGFP (lacking the
C-terminal retroCspA extension). It can be seen that despite
its high molecular weight status, the soluble EGFP-T-retroC-
spA fusion is highly structured, adopting a typical b-sheet rich
structure characterized by a 218 nm mean residue ellipticity
(MRE) minimum. Comparison with the far-UV CD spectrum
of control EGFP protein indicates that there is considerable
similarity between the spectra of the two proteins in the region
of wavelengths ranging from 210 to 250 nm, as would be antic-
ipated if EGFP exists in a native-like fold within the high
molecular weight soluble aggregates. Notably, the presence
of the retroCspA sequence in the fusion could be expected to
shift the zero crossover point of the fusion proteins spectrum
towards lower wavelengths on account of its greater contribu-
tion to the negative mean residue ellipticity below 210 (because
retroCspA is less folded [10]), and indeed this is observed. The
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while the fusion protein has a crossover below 200 nm. It
appears, therefore, that EGFP in the fusion is native in this
soluble aggregated form.
3.8. Soluble EGFP-T-retroCspA structural stability; Akin to
native EGFP
Thermal melting studies of the soluble aggregated form of
the fusion protein, and the native protein, were carried out
by measuring changes in the MRE at 218 nm as a function
of temperature. For EGFP-T-retroCspA, the data is shown
in Fig. 4D which plots the change in the MRE value at
218 nm as a function of temperature, during heating from
25 C to 95 C at a rate of change of temperature of 3 C per
minute. At lower temperatures, there is some consolidation
of structure ostensibly on account of the retroCspA compo-
nent, since retroCspA is known to show some structural
consolidation with heating due to the heat-induced transfor-
mation of polyproline type II (PPII) structures into beta
sheets. What is important to note, however, is the fact that
the EGFP-T-retroCspA fusion is able to withstand tempera-
tures up to approx 85 C without any loss of secondary struc-
ture. At higher temperatures, it starts losing structure through
a melting transition that we ﬁnd to be irreversible. As is well
known, native GFP and its enhanced form, EGFP, are very
stable to heat, requiring a combination of 90 C and 6 MFig. 5. Far-UV CD spectra of diﬀerent proteins acquired at 25 C (black), af
EGFP-T-retroCspA. Panel B: green ﬂuorescent protein. Panel C: retroCspAGdnCl to undergo structural unfolding. The various panels
in Fig. 5 show the far-UV CD spectra of the EGFP-T-retroC-
spA fusion (Fig. 5A), the control wild-type GFP (Fig. 5B), and
retroCspA (Fig. 5C), at room temperature, upon heating to
90 C and upon cooling back to room temperature, to illus-
trate how these diﬀerent proteins respond to thermal destabili-
zation/unfolding and cooling. From the data in Figs. 4 and 5, it
is evident that but for the fact that the fusion protein loses
structure substantially upon heating to 90 C (Fig. 5A), while
the control (Fig. 5B) gains structure, the fusion protein is
clearly extremely thermostable, surviving structurally almost
until 80–85 C (Fig. 4D), comparing favorably with the known
thermostability of GFP/EGFP that is evident also in Fig. 5B.
This thermostability of the fusion protein between 25 C and
85 C is evidence of the native-like structural status of the
EGFP domain within the fusion, since it is clear from the ret-
roCspA spectra in Fig. 5C that neither the far-UV CD spectra
of fusion protein (Fig. 4C), nor its thermostability (Fig. 4D)
can owe mainly to retroCspA. The question, however, arises
about why the folded EGFP domain within the soluble
EGFP-T-retroCspA fusion fails to show the stability displayed
by GFP at 90 C, or the structural consolidation displayed by
GFP upon heating. The answer would seem to be tied in with
the lack of a completely native-like structure in this soluble
aggregated state, which is evident also in the ﬂuorescence data
presented in the very next section. Perhaps, the inability of theter heating to 90 C (red) and upon cooling to 25 C (green). Panel A:
.
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form like the control GFP (owing to steric reasons) causes it to
undergo somewhat more facile structural melting, under the
inﬂuence of the retroCspA sequence.
3.9. Soluble EGFP-T-retroCspA tertiary structure: quenched
green ﬂuorescence
Unlike the precipitated fusion protein which showed the typ-
ical GFP ﬂuorescence, the soluble high molecular weight
aggregates of EGFP-T-retroCspA showed no detectable green
ﬂuorescence whatsoever in course of spectroﬂuorimetry (data
not shown), despite the obvious presence of a folded EGFP
domain. This suggests that there is deformation of the native
structure of the EGFP domain in the soluble aggregated state,
which also explains the somewhat poorer thermostability re-
ported in Section 3.8. Further, this soluble aggregated form
also did not show any ThT binding or ﬂuorescence, suggesting
that retroCspA-based aggregation could not proceed to a stage
where the amyloid-like microstructure required for ThT bind-
ing forms (data not shown).
3.10. Implications for the beta-zipper propagation of amyloid
structures
It is known that disordered polypeptide segments are neces-
sary for ﬁbril formation, e.g., studies with apomyoglobin have
suggested that ﬁbril formation depends on the presence of dis-
ordered polypeptide segments as well as the prevalence of con-
ditions selectively unfavorable to folding [5]. When such
disordered segments associate during ﬁbril formation, what
happens to the ordered segments? Do stable structural do-
mains resist conformational change? What brings about the
conformational change? One possibility is that inter-strand
formation of beta sheets begins with the mutual approach of
unstructured regions or strands in extended conformation, in
neighboring molecules, through the formation of a few initial
hydrogen bonds. With every hydrogen bond formed that man-
ages to form between the carbonyl group on one strand and
the amide group on a proximal strand, another set of amide
and carbonyl groups located further along either strand be-
come brought into close proximity (and appropriate geometry)
in the correct register for the formation of another hydrogen
bond. This can lead to the propagation of a sheet in either
direction through a zipper-like mechanism, with successive res-
idues becoming co-opted into these intermolecular sheets from
either an unstructured state, or even from a structured state.
Assuming that intermolecular sheets may be formed and
extended by such zipper-like mechanisms, what could be antic-
ipated to happen when an advancing sheet approaches the
boundary of a stable structured domain? In principle, the do-
main could either halt further progression of the sheet because
of its intrinsically high stability, and its inability to undergo
profound conformational change or, alternatively, surrender
to the advancing sheet and change conformation to become
a part of the sheet. In theory, a very stable protein domain
could halt, at its boundaries, the propagation of a beta sheet
advancing towards it through a zipper-like mechanism,
whereas a less stable domain would be more likely to allow
the propagating sheet to advance past its boundaries, destabi-
lize it and thus destroy its folded structure.
The CD data with the soluble aggregates and the ﬂuorescence
data with the precipitates indicate that the extremely stableEGFP domain successfully resists structural reorganization
by the advances of the retroCspA sequence present in fusion,
although this does not prevent the aggregation and precipita-
tion, or amyloid formation caused by retroCspA per se.
Whether the native-like or even native state of the EGFP
domain can be claimed for all molecules in the aggregated pop-
ulation, or only for a fraction which contributes to the spectro-
scopic data, of course, cannot be answered. Still, we emphasize
that our data shows that native or native-like EGFP can partic-
ipate in soluble aggregates and amyloids without necessarily
undergoing structural destabilization and unfolding.4. Conclusions and perspectives
We examined the structural-biochemical behavior of a
fusion construct physically joining enhanced green ﬂuorescent
protein (EGFP), a highly thermally (and thermodynamically)
stable protein with a beta barrel structure, to retroCspA, a
non-naturally-occurring amyloidogenic protein derived by
reversing the sequence of cold shock protein A, a model beta
sheet protein. Our intention was to check whether, or not,
the EGFP domain is at all amenable to aggregation on account
of the amyloidogenic sequence present in fusion at its C-termi-
nus. Our data seems to demonstrate conclusively that retroC-
spA causes the fusion protein to aggregate both intracellularly,
upon expression, and following puriﬁcation. Step-wise re-
moval of denaturant and maintenance of NaCl helps to keep
aggregates soluble, while single-step dialysis into NaCl-lacking
buﬀer causes formation of precipitated, insoluble amyloid-like
forms displaying ThT binding and ﬂuorescence, as well as
EGFP ﬂuorescence. The insoluble form is associated with
green ﬂuorescence, both when produced in the cell and subse-
quently, upon dialysis. However, when the fusion construct
adopts a soluble high molecular weight aggregated form
through step-wise folding into 1 M NaCl-containing buﬀer,
these soluble aggregates show no green ﬂuorescence.
These data are made especially interesting by the earlier
observation that fusions of the Alzheimers peptide Ab 1–42
with GFP produce no ﬂuorescence when such fusion con-
structs undergo aggregation (because the Ab 1–42 component
of the fusion prevents GFP folding and ﬂuorescence), whereas
certain mutations which stop aggregation of the Ab 1–42 seg-
ment allow GFP to fold and ﬂuoresce within such fusion con-
structs [11]. We suggest that the reason that the Ab 1–42
segment prevents ﬂuorescence of GFP could have to do with
the presence of the amyloidogenic peptide at the N-terminus
of GFP. In data that has not been presented here, we also
found that when retroCspA is fused to the N-terminus of
EGFP, rather than to its C-terminus (with or without a linker
sequence separating it from EGFP), the fusion proteins thus
obtained, although easily extracted from inclusion bodies by
urea, were non-ﬂuorescent under all conditions – both within
the cell after overexpression, and after refolding, unlike the
C-terminal fusion reported here – as well as extremely precip-
itation-prone. We could not obtain a soluble form of such a fu-
sion, except by maintenance in the denaturant-containing
solutions used to extract the protein from inclusion bodies.
We suggest that the explanation for this could be that when
GFP (or EGFP) is at the N-terminus of the fusion, it rapidly
folds co-translationally to a structure that is not perturbed,
S. Sharma, P. Guptasarma / FEBS Letters 582 (2008) 2203–2211 2211or prevented from folding to a mature protein by the amyloi-
dogenic sequence added later during translation. On the other
hand, when the amyloidogenic sequence is at the N-terminus,
the intermolecular interactions that it engages in before the
synthesis/folding of the GFP/EGFP component can be com-
pleted, causes the lack of folding and ﬂuorescence of the
GFP/EGFP domain. The data presented in this paper suggests
that if EGFP is given the opportunity to fold ﬁrst by being
present at the N-terminus of the fusion, it remains folded even
within the soluble aggregate, or precipitate, indicating that
folded stable protein domains can participate in amyloid for-
mation while resisting structural reorganization.
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